Your session is about to expire
← Back to Search
Mindfulness Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
N/A
Waitlist Available
Led By Stephen P Becker, PhD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention
Awards & highlights
Summary
This trial will look at whether mindfulness meditation (MAPs) can help treat ADHD & co-occurring cognitive disengagement syndrome (CDS) in adolescents. Results will provide key data on treating CDS in those with ADHD.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after the intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mindfulness
Secondary outcome measures
Attention Deficit Disorder
Syndrome
Change in mind wandering: Mind-Wandering Questionnaire (MWQ)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Mindfulness TreatmentExperimental Treatment1 Intervention
This arm consists of the mindfulness treatment that will be administered to all participants in the single-arm open trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindful Awareness Practices (MAPs)
2017
N/A
~100
Find a Location
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiLead Sponsor
816 Previous Clinical Trials
6,575,152 Total Patients Enrolled
33 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
4,051 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Stephen P Becker, PhDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
Share this study with friends
Copy Link
Messenger